Mostrando resultados 8 a 24 de 24
< Anterior
Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
openAccess | | 24-mar-2016 | Mice lacking endoglin in macrophages show an impaired immune response | Ojeda-Fernández, María Luisa CSIC; Recio-Poveda, Lucía ; Aristorena, Mikel CSIC; Lastres, Pedro ; Blanco, Francisco J. CSIC ; Gallardo-Vara, Eunate CSIC ORCID; Casas-Engel, Mateo de las CSIC; Corbí, Angel L. ; Bernabéu, Carmelo CSIC ORCID ; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 26-jun-2013 | MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells | Tabruyn, Sebastien P.; Hansen, Sylvain; Ojeda-Fernández, María Luisa CSIC; Bovy, Nicolas; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Bernabéu, Carmelo CSIC ORCID ; Martial, Joseph A.; Botella, Luisa María CSIC ORCID ; Struman, Ingrid | artículo |
openAccess | | 23-feb-2017 | Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1 | Albiñana, Virginia CSIC; Zafra, María Paz CSIC ORCID; Colau, Jorge; Zarrabeitia, Roberto; Recio-Poveda, Lucía ; Olavarrieta, Leticia CSIC; Pérez-Pérez, Julián; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 16-oct-2023 | Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth | Cabrera-Montes, Jorge; Aguirre, Daniel T.; Viñas-López, Jesús; Lorente-Herraiz, Laura; Recio-Poveda, Lucía ; Albiñana, Virginia CSIC; Pérez Pérez, Julián; Botella, Luisa María CSIC ORCID ; Cuesta, Ángel M. CSIC ORCID | artículo |
openAccess | | 3-may-2012 | Propranolol as an antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia | Albiñana, Virginia CSIC; Recio-Poveda, Lucía ; Zarrabeitia, Roberto; Bernabéu, Carmelo CSIC ORCID ; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 4-ago-2022 | Propranolol: a “pick and roll” team player in benign tumors and cancer therapies | Albiñana, Virginia CSIC; Gallardo-Vara, Eunate CSIC ORCID; Casado-Vela, Juan CSIC ORCID CVN; Recio-Poveda, Lucía ; Botella, Luisa María CSIC ORCID ; Cuesta, Ángel M. CSIC ORCID | artículo |
closedAccess | | abr-2010 | Reduced plasma levels of Ang-2 and sEng as novel biomarkers in Hereditary Hemorrhagic Telangiectasia (HHT) | Ojeda-Fernández, María Luisa CSIC; Barrios, Laura CSIC ORCID; Rodríguez-Barbero, Alicia; Recio-Poveda, Lucía ; Bernabéu, Carmelo CSIC ORCID ; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 29-jun-2017 | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease | Albiñana, Virginia CSIC; Jiménez Escribano, Rosa María; Soler, Isabel; Rodríguez Padial, Luis; Recio-Poveda, Lucía ; Villar Gómez de las Heras, Karina; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 31-mar-2015 | Research on potential biomarkers in hereditary hemorrhagic telangiectasia | Botella, Luisa María CSIC ORCID ; Albiñana, Virginia CSIC; Ojeda-Fernández, María Luisa CSIC; Recio-Poveda, Lucía ; Bernabéu, Carmelo CSIC ORCID | artículo |
openAccess | | 2020 | Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding | Albiñana, Virginia CSIC; Cuesta, Ángel M. CSIC ORCID ; Rojas-P, Isabel de CSIC; Gallardo-Vara, Eunate CSIC ORCID; Recio-Poveda, Lucía ; Bernabéu, Carmelo CSIC ORCID ; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 27-abr-2021 | SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population | Marcos, Sol; Albiñana, Virginia CSIC; Recio-Poveda, Lucía ; Tarazona, Belisa; Verde-González, María Patrocinio; Ojeda-Fernández, María Luisa CSIC; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 29-nov-2023 | Tacrolimus as a promising drug for epistaxis and gastrointestinal bleeding in HHT | Álvarez-Hernández, Paloma; Patier, José-Luis; Marcos, Sol; Gómez del Olmo, Vicente; Lorente-Herraiz, Laura; Recio-Poveda, Lucía ; Botella, Luisa María CSIC ORCID ; Viteri-Noël, Adrián; Albiñana, Virginia CSIC | artículo |
openAccess | | 25-ago-2020 | Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from Von Hippel–Lindau disease | Albiñana, Virginia CSIC; Gallardo-Vara, Eunate CSIC ORCID; Rojas-P, Isabel de CSIC; Recio-Poveda, Lucía ; Aguado, Tania CSIC ORCID; Canto-Cano, Ana; Aguirre, Daniel T.; Serra, Marcelo M.; González-Peramato, Pilar; Martínez-Piñeiro, Luis; Cuesta, Ángel M. CSIC ORCID ; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 2021 | The endothelial landscape and its role in von hippel–lindau disease | Rojas-P, Isabel de CSIC; Albiñana, Virginia CSIC; Taranets, Lyudmyla; Recio-Poveda, Lucía ; Cuesta, Ángel M. CSIC ORCID ; Popov, Nikita; Kronenberger, Thales; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 11-abr-2022 | The role of propranolol as a repurposed drug in rare vascular diseases | Cuesta, Ángel M. CSIC ORCID ; Gallardo-Vara, Eunate CSIC ORCID; Casado-Vela, Juan CSIC ORCID CVN; Recio-Poveda, Lucía ; Botella, Luisa María CSIC ORCID ; Albiñana, Virginia CSIC | artículo |
openAccess | | 11-jul-2019 | The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease | Cuesta, Ángel M. CSIC ORCID ; Albiñana, Virginia CSIC; Gallardo-Vara, Eunate CSIC ORCID; Recio-Poveda, Lucía ; de Rojas, I.; Villar Gómez de las Heras, Karina; Aguirre, Daniel T.; Botella, Luisa María CSIC ORCID | artículo |
openAccess | | 2019 | Topically applied etamsylate: a new orphan drugfor HHT-derived epistaxis (antiangiogenesisthrough FGF pathway inhibition) | Albiñana, Virginia CSIC; Giménez-Gallego, Guillermo CSIC; García-Mato, Ángela CSIC ORCID; Palacios, Patricia; Recio-Poveda, Lucía ; Cuesta, Ángel M. CSIC ORCID ; Patier, José-Luis; Botella, Luisa María CSIC ORCID | artículo |